医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

GenoLogics Enters Agreement with Illumina to Provide Laboratory Information System for HiSeq X Ten System

2014年09月04日 PM09:00
このエントリーをはてなブックマークに追加


 

VICTORIA, British Columbia

GenoLogics today announced it has been selected by Illumina as the preferred laboratory information management system (LIMS) provider to support HiSeq X Ten sequencing system customers. Under the agreement, the companies are working closely to provide support for HiSeq X Ten whole-genome workflows and analysis pipelines, including those to be used inside of Illumina. Additionally, Illumina will be using GenoLogics’ LIMS to support its collaboration with Genomics England to sequence 100,000 genomes.

The agreement pairs the $1,000 genome with the preeminent laboratory information management system, further empowering the sequencing community to sequence human whole genomes.

According to Alex Dickinson, Senior Vice President of Strategic Initiatives at Illumina, “Illumina is pleased to be working with GenoLogics to ensure HiSeq X Ten customers receive the LIMS support they need. Scaling a lab to deliver the $1,000 genome presents unique challenges and GenoLogics has the demonstrated ability and understanding of our technologies to support these labs.”

“Clarity LIMS leads the industry because it helps sequencing labs improve overall efficiency, turnaround time, and the accuracy of data,” states Michael Ball, CEO of GenoLogics. “This agreement was the logical next step with Illumina because it builds on these efficiencies with enhanced automation and throughput, enabling customers to rapidly scale their sequencing operations.”

About GenoLogics

GenoLogics develops the industry-leading laboratory information management system (LIMS) for life sciences organizations. Clarity LIMS helps labs gain efficiencies and throughput with increased accuracy, fast turnaround, sample traceability, and preconfigured instrument integrations. Whether your lab is regulated or unregulated, big or small, Clarity LIMS will streamline your lab operations so that you can focus on advancing healthcare. Founded in 2002 and privately held, GenoLogics is based in Victoria, British Columbia. www.genologics.com

CONTACT

GenoLogics Life Sciences Software
Lisa Owen, Communications Manager
1-250-483-7011
lisa.owen@genologics.com

同じカテゴリーの記事 

  • LC-Plasma-based Vaccine Research Selected for SCARDA Project
  • 一份具有里程碑意义的报告证明,大量使用尼古丁不会导致健康问题高发
  • Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)
  • Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
  • Inocras Hong Kong Limited, in Collaboration with Cancerinformation.com.hk Charity Foundation and Sponsored by AstraZeneca Hong Kong, Offers Free BRCA or HRD Genetic Testing for Eligible Cancer Patients in Hong Kong and Macau